Apart from RBM15, which has been reported to recruit the core m6A methyltransferase to specific sites via recognition of U-rich sequences [48], none of the other components of the m6A methyltransferase complex show increased expression in breast cancers (Fig. S3A–G). This evidence concerns the gene RBM15 and breast carcinoma.